BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 26180079)

  • 1. Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts.
    Cassidy JW; Caldas C; Bruna A
    Cancer Res; 2015 Aug; 75(15):2963-8. PubMed ID: 26180079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas.
    Jakša R; Karolová J; Svatoň M; Kazantsev D; Grajciarová M; Pokorná E; Tonar Z; Klánová M; Winkowska L; Maláriková D; Vočková P; Forsterová K; Renešová N; Dolníková A; Nožičková K; Dundr P; Froňková E; Trněný M; Klener P
    Lab Invest; 2022 Sep; 102(9):957-965. PubMed ID: 35488033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ewing Sarcoma PDX Models.
    Surdez D; Landuzzi L; Scotlandi K; Manara MC
    Methods Mol Biol; 2021; 2226():223-242. PubMed ID: 33326106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer.
    Pu X; Zhang R; Wang L; Chen Y; Xu Y; Pataer A; Meraz IM; Zhang X; Wu S; Wu L; Su D; Mao W; Heymach JV; Roth JA; Swisher SG; Fang B
    J Transl Med; 2018 Nov; 16(1):328. PubMed ID: 30477533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer.
    Bonazzi VF; Kondrashova O; Smith D; Nones K; Sengal AT; Ju R; Packer LM; Koufariotis LT; Kazakoff SH; Davidson AL; Ramarao-Milne P; Lakis V; Newell F; Rogers R; Davies C; Nicklin J; Garrett A; Chetty N; Perrin L; Pearson JV; Patch AM; Waddell N; Pollock PM
    Genome Med; 2022 Jan; 14(1):3. PubMed ID: 35012638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-derived xenografts (PDXs) as model systems for human cancer.
    Invrea F; Rovito R; Torchiaro E; Petti C; Isella C; Medico E
    Curr Opin Biotechnol; 2020 Jun; 63():151-156. PubMed ID: 32070860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies.
    Hanna C; Kwok L; Finlay-Schultz J; Sartorius CA; Cittelly DM
    J Vis Exp; 2016 Nov; (117):. PubMed ID: 27929464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of patient-derived tumor xenograft models and tumor organoids.
    Yoshida GJ
    J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.
    Prasetyanti PR; van Hooff SR; van Herwaarden T; de Vries N; Kalloe K; Rodermond H; van Leersum R; de Jong JH; Franitza M; Nürnberg P; Todaro M; Stassi G; Medema JP
    Int J Cancer; 2019 Jan; 144(2):366-371. PubMed ID: 30151914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries.
    Veeranki OL; Tong Z; Mejia A; Verma A; Katkhuda R; Bassett R; Kim TB; Wang J; Lang W; Mino B; Solis L; Kingsley C; Norton W; Tailor R; Wu JY; Krishnan S; Lin SH; Blum M; Hofstetter W; Ajani J; Kopetz S; Maru D
    Dis Model Mech; 2019 Dec; 12(12):. PubMed ID: 31732509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma.
    Landuzzi L; Manara MC; Lollini PL; Scotlandi K
    Cells; 2021 Feb; 10(2):. PubMed ID: 33671173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts.
    Cybulska M; Olesinski T; Goryca K; Paczkowska K; Statkiewicz M; Kopczynski M; Grochowska A; Unrug-Bielawska K; Tyl-Bielicka A; Gajewska M; Mroz A; Dabrowska M; Karczmarski J; Paziewska A; Zając L; Bednarczyk M; Mikula M; Ostrowski J
    Biomed Res Int; 2018; 2018():2954208. PubMed ID: 30662905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
    Chen Y; Zhang R; Wang L; Correa AM; Pataer A; Xu Y; Zhang X; Ren C; Wu S; Meng QH; Fujimoto J; Jensen VB; Antonoff MB; Hofstetter WL; Mehran RJ; Pisimisis G; Rice DC; Sepesi B; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Heymach JV; Fang B
    Cancer; 2019 Nov; 125(21):3738-3748. PubMed ID: 31287557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Derived Xenograft Models in Cancer Research: Methodology, Applications, and Future Prospects.
    Aslani S; Saad MI
    Methods Mol Biol; 2024; 2806():9-18. PubMed ID: 38676792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of Metastatic Cholangiocarcinoma Patient-Derived Xenograft Models.
    Yáñez-Bartolomé M; Serra-Camprubí Q; Arenas EJ; Escorihuela M; Castet F; Fabregat-Franco C; Querol J; Arribas J; Peiró S; Macarulla T; Tian TV
    Methods Mol Biol; 2024; 2806():139-151. PubMed ID: 38676801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-derived xenograft (PDX) models, applications and challenges in cancer research.
    Abdolahi S; Ghazvinian Z; Muhammadnejad S; Saleh M; Asadzadeh Aghdaei H; Baghaei K
    J Transl Med; 2022 May; 20(1):206. PubMed ID: 35538576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.
    Kawaguchi T; Foster BA; Young J; Takabe K
    J Mammary Gland Biol Neoplasia; 2017 Jun; 22(2):131-139. PubMed ID: 28451789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study.
    Xu C; Yan L; An Q; Zhang S; Guan X; Wang Z; Lv A; Liu D; Liu F; Dong B; Zhao M; Tian X; Hao C
    Int J Med Sci; 2022; 19(8):1241-1253. PubMed ID: 35928724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
    Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
    Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response.
    Zhang F; Wang W; Long Y; Liu H; Cheng J; Guo L; Li R; Meng C; Yu S; Zhao Q; Lu S; Wang L; Wang H; Wen D
    Cancer Commun (Lond); 2018 Sep; 38(1):60. PubMed ID: 30257718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.